Results 131 to 140 of about 21,916 (184)
Cardiac autonomic ganglion ablation for refractory coronary artery spasm after PCI: a case report. [PDF]
Front Cardiovasc MedQu F +10 more
europepmc +1 more source
Intracoronary prourokinase for coronary embolism after aortic valve replacement: a viable treatment option? [PDF]
J Cardiothorac SurgFan H, Wang H, He C, Zhai C.
europepmc +1 more source
Coronary Conundrum: Anomalous Pan-Coronary Origin from the Right Sinus with a "Type X" Dual LAD. [PDF]
Methodist Debakey Cardiovasc JJ A +4 more
europepmc +1 more source
Impact of COVID-19 history on the prevalence of coronary slow flow: a comparative study in unstable angina patients. [PDF]
Front Cardiovasc MedAlan S, Alan B.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studies
Contemporary Clinical Trials, 1989Prior to each randomized study, the Thrombolysis in Myocardial Infarction (TIMI) investigators conducted pilot studies following the treatment protocols for the randomized studies except that patients in the pilot studies were systematically assigned to known treatments. The pilot studies were performed to assess the feasibility of the protocols and to
Genell L Knatterud
exaly +3 more sources
The Thrombolysis in Myocardial Infarction (TIMI) Trial
New England Journal of Medicine, 1985W Ganz
exaly +3 more sources
Implications of the TIMI Trials
1990The TIMI Trials consist of three primary studies plus numerous ancillary observations. TIMI I was the direct reperfusion comparison between streptokinase and TPA. The central observations were: Higher reperfusion rates with TPA; Equivalent frequencies of bleeding complications; No differences in clinical outcome parameters; Only early reperfusion ...
openaire +2 more sources